Karen Dahlsveen

Statistics

Publications

Citations

276

H-Index

Active since

2013

Affiliations

University of Birmingham(Current)

Karolinska University Hospital

Great Ormond Street Hospital

KU Leuven

University College London

Karen Dahlsveen is an author at University of Birmingham specializing in autoimmune vasculitis, immunomodulatory drug therapy, and clinical immunology.

Publications per year

2013–2019

Publications

Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial

Rachel Jones, Thomas F. Hiemstra, José Ballarín et al. · Annals of the Rheumatic Diseases · 2019 · 228 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

A randomized trial of mycophenolate mofetil versus cyclophosphamide for remission induction of ANCA-associated vasculitis: “MYCYC”. On behalf of the European vasculitis study group

Rachel Jones, Lorraine Harper, José Ballarín et al. · La Presse Médicale · 2013 · 48 citations

Medicine, Pharmacology, Pharmacotherapy +14

1–2 of 2